arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Serina Therapeutics, Inc.

SER

$2.39 ▲ +0.03 (+1.27%) at close

32 Visible periods

31 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Neutral Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Serina Therapeutics, Inc. shows mixed fundamentals. Return on Invested Capital remain bright spots. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $28.8M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC None

FCF / Share $-0.38

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

32-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↑ +100.0% —

Net Income Profit after all expenses

$-6.90M

↓ -43.3% —

Operating Margin Operating profit as % of sales

7.8%

↑ +101.7% —

FCF / Share Free cash flow per share

$-0.38

↑ +13.9% —

Long-Term Debt Long-term obligations

$11.15M

↓ -28.7% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

Return on Invested CapitalReturn on Invested Capital of 64985.2% is excellent on an absolute basis (target > 10%)

warning

Bearish Risks

Interest CoverageInterest Coverage of -1413.06x is weak on an absolute basis (target > 5x)
FCF / Net IncomeFCF / Net Income of 0.94x is caution on an absolute basis (target > 1x)

Health Breakdown

Financial Health ↓

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2018 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2017 10-K ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2016 10-K ↗
Revenue Growth YoY (%)	—	100.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1150%)	N/M	154.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1836%)	N/M	N/M	-79.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1089%)	466.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5733%)	-50.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-725%)	38487.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+480994%)	644.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+7956%)	-25.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-412%)	100.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1150%)	-70.4% Weak → Weak Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-980%)	-62.5% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-881%)	-67.6% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-945%)	-91.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1238%)	-82.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1136%)	-65.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-915%)	-17.8% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-322%)	-37.1% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-563%)	-27.2% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-440%)	-81.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1123%)	-90.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1229%)	-62.8% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-885%)	—	—	—	—	—	—	—
EPS Growth YoY (%)	-18.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-14.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	87.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	85.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	93.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	N/M	-133.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	-350.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-43.3% Weak Weak Year-over-year change in net income	-21.8% Weak Weak Year-over-year change in net income	N/M	N/M	49.0% Excellent Excellent Year-over-year change in net income	N/M	N/M	N/M	-188.0% Weak ↓ Weak Declining Year-over-year change in net income	N/M	-121.8% Weak ↓ Weak Declining Year-over-year change in net income	-1.9% Weak ↑ Weak Improving Year-over-year change in net income	-21.1% Weak ↓ Weak Declining Year-over-year change in net income	-25.3% Weak ↓ Weak Declining Year-over-year change in net income	-24.6% Weak ↓ Weak Declining Year-over-year change in net income	-5.8% Weak ↓ Weak Declining Year-over-year change in net income	-29.6% Weak ↓ Weak Declining Year-over-year change in net income	—	23.1% Good ↑ Good Improving Year-over-year change in net income	8.0% Fair → Fair Stable Year-over-year change in net income	34.5% Excellent ↑ Excellent Improving Year-over-year change in net income	—	-18.2% Weak ↑ Weak Improving Year-over-year change in net income	-39.3% Weak Weak Year-over-year change in net income	-1256.2% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	13.9% Fair Fair Year-over-year change in free cash flow	—	—	—	22.3% Good Good Year-over-year change in free cash flow	—	—	—	99.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	121.3% Excellent Excellent Compound annual revenue growth over 3 years	—	—	-16.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	11.3% Good ↓ Good Declining Compound annual revenue growth over 3 years	-55.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	169.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-1.0% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-41.5% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-51.7% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-66.7% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-71.3% Weak → Weak Stable Compound annual revenue growth over 3 years	-70.4% Weak Weak Compound annual revenue growth over 3 years	-72.4% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	—	—	—	23.6% Excellent Excellent Compound annual revenue growth over 5 years	—	—	-48.3% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-35.7% Weak Weak Compound annual revenue growth over 5 years	-53.9% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2018 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2017 10-K ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2016 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	7.8% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-48%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-459.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3166%)	—	—	—	—
Effective Tax Rate (%) (%)	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	34.0% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+184%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-415.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3566%)	-98.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-919%)	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	3.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-263.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—
FCF / Net Income (x)	0.67x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.81x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.68x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.17x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.12x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.57x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.49x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.60x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.26x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.75x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	8.54x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2018 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2017 10-K ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2016 10-K ↗
Return on Invested Capital (%)	—	13252.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-286.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-244.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-272.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-683.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	160.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	18.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	42.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-0.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	6.8% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	6.7% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	8.6% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	8.2% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	-225.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	9.5% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	14.0% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	-107.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	16.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	21.1% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	28.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	35.9% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	-14.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-40.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-37.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	—	-89.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-51.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-62.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-87.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-82.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-71.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-36.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	2.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-55.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-77.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-61.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-75.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-59.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-69.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-86.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-69.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-59.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-13.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-20.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-33.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	—	—	-260.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1837%)	—	-283.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1986%)	—	-10.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-168%)	-31.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-312%)	219.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1360%)	-3.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-122%)	19.6% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+31%)	12.0% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-20%)	16.5% Good → Good Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+10%)	15.7% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	16.1% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+7%)	19.8% Good → Good Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+32%)	23.4% Excellent → Excellent Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+56%)	18.2% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+22%)	19.7% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+31%)	30.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+100%)	34.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+130%)	—	—	—	—	—	-49.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-430%)	-28.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-291%)	-3.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-121%)	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2018 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2017 10-K ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2016 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	-0.81x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-235%)	—	—	—	—	—	—	—	-1.04x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-273%)	—	—	-1.12x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-286%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	-2774.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-3866.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-23.44x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-0.78x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.38x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1.96x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1.82x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1.68x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-293.14x Weak Weak Operating income divided by interest expense Optimal: > 5x	-6.33x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-312.43x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-2397.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-592.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	-429.71x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—
Net Debt (USD)	$-24.53M	$-3.06M	$-8.62M	$-6.04M	$-4.27M	$-3.67M	$7.97M	$-6.06M	$-8.71M	$-7.62M	$-397.00K	$-261.00K	$-280.00K	$-645.00K	$15.18M	$-702.00K	$-448.00K	$12.62M	$-731.00K	$-615.00K	$-809.00K	$-527.00K	—	—	—	$-6.71M	$-3.77M	$-5.81M	$-8.52M	$-7.38M	$-7.38M	$-259.00K
Debt / EBITDA (x)	—	—	—	—	—	—	-2.10x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	-10.09x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	-7.07x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2018 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2017 10-K ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2016 10-K ↗
Revenue per Share (USD)	—	—	$0.00	$0.01	$0.00	—	$0.00	—	$0.00	—	—	—	$0.33	—	$0.29	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.58	$-0.31	$-0.45	$-0.66	$-0.49	$-0.27	$0.16	$-5.38	$-3.38	$0.42	$-173.38	$-86.69	—	$-334.51	$-74.30	$-86.69	$-86.69	$-74.30	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.38	—	$-0.37	$-0.38	$-0.44	—	—	—	$-0.57	—	—	—	$-60.86	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	—	$-0.00	$0.17	$0.18	$0.17	$0.07	$-1.55	$-1.86	$-0.51	$-13.40	$-898.54	$-723.60	$-649.16	$-561.68	$-492.91	$-431.39	$-376.87	$-386.19	$-324.33	$-269.37	$-197.89	$-168.09	—	—	—	$257.39	$142.72	$222.04	$257.39	$267.13	—	—
Tangible Book Value per Share (USD)	—	$-0.00	$0.17	$0.18	$0.17	$0.07	$-1.61	$-1.92	$-0.58	$-13.40	$-919.42	$-745.56	$-672.17	$-585.77	$-518.08	$-457.63	$-404.19	$-414.59	$-353.77	$-299.89	$-229.50	$-220.40	—	—	—	$163.76	$67.40	$142.07	$163.76	$198.36	—	—
Basic Weighted Avg Shares (shares)	12.05M	—	10.34M	10.00M	9.76M	—	8.85M	8,514	2.79M	—	31	31	30,645	—	30,641	31	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2018 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2017 10-K ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2016 10-K ↗
Working Capital (USD)	$20.13M	$2.52M	$2.71M	$4.43M	$3.40M	$3.31M	$-8.09M	$-3.72M	$-5.12M	$6.21M	$-2.06M	$-23.16M	$-20.78M	$-7.62M	$-7.62M	$-7.36M	$-8.27M	$-6.73M	$-5.12M	$-3.71M	$-1.79M	$-3.07M	—	—	—	—	$1.78M	$4.05M	—	—	—	—
LT Debt (USD)	—	—	—	—	—	—	$11.15M	—	—	—	—	—	—	—	$15.65M	—	—	$13.20M	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	—	$-37.00K	$1.76M	$1.80M	$1.70M	$641.00K	$-13.77M	$-16.36M	$-4.31M	$-32.29M	$-27.54M	$-22.18M	$-19.89M	$-17.21M	$-15.10M	$-13.22M	$-11.55M	$-11.83M	$-9.94M	$-8.25M	$-6.06M	$-5.12M	—	—	—	$7.45M	$4.34M	$6.75M	$7.45M	$7.28M	—	—

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2018 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2017 10-K ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2016 10-K ↗
Sales/Revenue/Turnover (USD)	—	$0.00	$0.00	$130.00K	$0.00	$-14.00K	$14.00K	$51.00K	$5.00K	$3.09M	$67.00K	$9.00K	$10.00K	$8.00K	$9.00K	$12.00K	$5.00K	$27.00K	$24.00K	$37.00K	$56.00K	$158.00K	$69.00K	$45.00K	$89.00K	$217.00K	$380.00K	$464.00K	$239.00K	—	—	—
Depreciation Expense (USD)	$0.00	—	$0.00	$0.00	—	—	—	$24.00K	$23.00K	—	—	—	—	—	—	—	—	—	—	—	—	$329.00K	$123.00K	$124.00K	$123.00K	$20.00K	$23.00K	$10.00K	$15.00K	—	—	—
Net Income, GAAP (USD)	$-6.90M	$-3.34M	$-4.58M	$-6.45M	$-4.81M	$-2.74M	$1.41M	$5.20M	$-9.44M	$1.05M	$-5.40M	$-2.67M	$-3.28M	$-2.70M	$-2.44M	$-2.62M	$-2.71M	$-2.16M	$-1.96M	$-2.47M	$-2.09M	—	$-2.54M	$-2.69M	$-3.19M	—	$-2.15M	$-1.93M	$-235.00K	—	—	—
Operating Cash Flow (USD)	$-4.57M	$-6.03M	$-3.85M	$-3.75M	$-4.32M	$-4.59M	—	—	$-1.58M	$121.00K	—	—	$-1.86M	$-1.32M	—	—	$-1.64M	$-1.65M	—	—	$-2.63M	$-1.62M	$-1.89M	$-2.24M	$-2.06M	$-246.00K	—	—	$-2.00M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 32 quarters

Serina Therapeutics, Inc.

Analytical Summary

32-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare SER with peers